Inicio > Cardiología > Infección por marcapasos permanente > Página 5

Infección por marcapasos permanente

REFERENCIAS BIBLIOGRÁFICAS

  1. Baddour L M, Bettmann MA, Bolger AF: Nonvalvular cardiovascular device-related infections. Circulation 2003; 108: 2015-31.
  2. Mela T, Mc Govern BA, Garan H: Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J cardiol 2001; 88: 750-753.
  3. Frame R, brodman RF, Furman S, Andrews CA, Gross JN: Surgical removal of infected transvenous pacemaker leads. Pacing Clin Electrophysiol 1993; 2343-8.
  4. Lai KK, Fontecchio SA: Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control and management. Clin Infect Dis 1998; 27: 265-69.
  5. Smith PN, Vidaillet HJ, Hayes JJ: Endotak Lead Clinical Investigators: Infections with nonthoracotomy implantable cardioverter defribilators: can these be prevented?. Pacing Clin Electrophysiol 1998; 21: 42-55.
  6. Hill PE: Complications of permanent transvenous cardiac pacing: a 14-year review of all trnasvenous pacemakers inserted at one community hospital. Pacing Clin Electrophysiol 1987; 10: 564-70.
  7. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007; 49: 1851-9.
  8. Durak DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96:200-9.
  9. Yoo HS, Pastori JD, Chiale PA. Las infecciones vinculadas a los dispositivos antiarritmicos implantables. Rev Electro y Arritmias 2009; 4:131-138.
  10. Klug D, Balde m, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116: 1349-55.
  11. Caro E, Reus SJ, García A, Piñar D. Curación de un caso de infección de marcapasos sin su extracción completa. Cartas científicas/Enferm Infecc microbiol Clin. 2011; 29(2):156-161.
  12. Ferguson TB Jr, Ferguson L, Crites K, Crimmins-Reda P. T he additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg 2006 111:742-52.
  13. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010; 121: 458-77.
  14. Wilkoff BL, Love CJ, Byrd CI, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009; 6:1085-104.
  15. Love CJ, Wilkoff BL, Byrd CI, et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. Pacing Clin Electrophysiol 2000; 23:544-51.
  16. Hurst LN, Evans HB, Windle B, Klein GJ .The salvage of infected cardiac pacemaker pockets using a closed irrigation system. Pacing Clin Electrophysiol 1986; 9:785-792.
  17. Golden GT, Lovet WL, Harrah JD, Wellons HA, Nolan SP. The treatment of extruded and infected permanent cardiac pulse generators: Application of a technique of closed irrigation. Surgery 1973; 74:575-579.
  18. Wazni O, Epstein LM, Carillo RG, et al. Lead extraction in the contemporary setting: the LexICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol 2010; 55:1055.
  19. Sloman G, Strathmore N: Permanent pacemaker lead extraction. PACE 1993; 16: 2331-2332.